tradingkey.logo
tradingkey.logo
Search

Urogen Pharma Ltd

URGN
Add to Watchlist
43.490USD
+1.750+4.19%
Close 09-16 16:00ET
2.13BMarket Cap
LossP/E TTM
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D

Today

+4.19%

5 Days

-3.36%

1 Month

-9.81%

6 Months

+132.19%

Year to Date

+85.70%

1 Year

+140.68%

Key Figures

42.070Open
43.670High
74.42KVolume
LossP/E TTM
13.20P/E Dynamic
--Dividend TTM
0.15%Turnover Ratio
41.740Prev. Close
42.385Low
3.21MTurnover
LossP/E Static
-16.05P/B
0.00%Div Yield TTM
-53.15%ROA
50.81052wk High
0.11Volume Ratio
-126.87MNet Profit
48.87MShares
-2.7353EPS TTM
1.61Beta
--ROE
15.86052wk Low
3.08%Amplitude
91.32%Gross Margin
2.13BMarket Cap
4.16Reward/Risk
4.11%Risk Rate
Recent
Earnings
More news coming soon, stay tuned...

Urogen Pharma Ltd's Score

0.05vs previous score
Forecast8.75
Financial Health8.60
Technical4.16
Valuation Dimensions9.20
Institutional Confidence10.00
Risk Assessment5.90

Media Coverage

Coverage Level

Very Low
Very High
Neutral

Analyst Rating

Strong Buy
Buy
Hold
Sell
Strong Sell
BuyCurrent Rating
60.000Target Price
+43.75%Upside Space
Current Rating2026-092026-082026-072026-062026-052026-042026-032026-02
Strong Buy44443333
Buy33334444
Hold11111111
Sell00000000
Strong Sell00000000

Urogen Pharma Ltd Technical Analysis

1m
5m
15m
30m
1h
2h
4h
D
W
M
1m
5m
15m
D

Technical Indicators

Sell

Summary

Neutral

Moving Average

Buy

Financial Indicators

Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

Earnings

Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
-0.28/-0.29
Revenue / Forecast
72.46M/63.53M

Urogen Pharma Ltd Profile

SectorBiotechnology & Medical Research
Ticker SymbolURGN
Number of employees235
CountryIsrael

Ownership

ShareholdersProportion
RTW Investments L.P.9.33%
Paradigm BioCapital Advisors LP9.18%
Morgan Stanley & Co. LLC5.12%
Jefferies LLC4.51%
Shareholder TypesProportion
Investment Advisor25.15%
Hedge Fund24.30%
Investment Advisor/Hedge Fund21.45%
Research Firm14.56%

FAQs

What is the current price of Urogen Pharma Ltd (URGN)?

The current price of Urogen Pharma Ltd (URGN) is 43.49.

What is the symbol of Urogen Pharma Ltd?

The ticker symbol of Urogen Pharma Ltd is URGN.

What is the 52-week high of Urogen Pharma Ltd?

The 52-week high of Urogen Pharma Ltd is 50.81.

What is the 52-week low of Urogen Pharma Ltd?

The 52-week low of Urogen Pharma Ltd is 15.86.

What is the market capitalization of Urogen Pharma Ltd?

The market capitalization of Urogen Pharma Ltd is 2.13B.

Is Urogen Pharma Ltd (URGN) currently rated as Buy, Hold, or Sell?

According to analysts, Urogen Pharma Ltd (URGN) has an overall rating of Buy, with a price target of 60.00.

What is the Earnings Per Share (EPS TTM) of Urogen Pharma Ltd (URGN)?

The Earnings Per Share (EPS TTM) of Urogen Pharma Ltd (URGN) is -2.74.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.